Phase 2 Pancreaticoduodenectomy Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery.
Patients Who Undergo Pancreaticoduodenectomy
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School35 enrolled1 locationNCT07514637
Recruiting
Phase 2
Prevention of Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy by Preoperative Radiotherapy : a Phase 2 Trial
Pancreatic FistulaPancreaticoduodenectomy
Assistance Publique - Hôpitaux de Paris50 enrolled1 locationNCT07370987
Recruiting
Phase 2
Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate
Pancreas CancerPeriampullary CancerPancreaticoduodenectomy+1 more
Minia University90 enrolled1 locationNCT07230509